vs

Side-by-side financial comparison of GREIF, INC (GEF) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

GREIF, INC is the larger business by last-quarter revenue ($994.8M vs $961.0M, roughly 1.0× DENTSPLY SIRONA Inc.). GREIF, INC runs the higher net margin — 17.6% vs -15.2%, a 32.7% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -21.4%). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -9.2%).

Greif, Inc. is a global leader in industrial packaging products and services based in Delaware, Ohio. Originally a manufacturer of barrels, the company is now focused on producing steel, fiber and plastic drums, IBCs, jerrycans, plastic bottles, closures, containerboard, corrugated products and adhesives. In 2018, the company ranked 617 on the Fortune 1000.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

GEF vs XRAY — Head-to-Head

Bigger by revenue
GEF
GEF
1.0× larger
GEF
$994.8M
$961.0M
XRAY
Growing faster (revenue YoY)
XRAY
XRAY
+27.6% gap
XRAY
6.2%
-21.4%
GEF
Higher net margin
GEF
GEF
32.7% more per $
GEF
17.6%
-15.2%
XRAY
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-9.2%
GEF

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GEF
GEF
XRAY
XRAY
Revenue
$994.8M
$961.0M
Net Profit
$174.6M
$-146.0M
Gross Margin
20.4%
46.1%
Operating Margin
25.8%
-14.5%
Net Margin
17.6%
-15.2%
Revenue YoY
-21.4%
6.2%
Net Profit YoY
1930.2%
66.0%
EPS (diluted)
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GEF
GEF
XRAY
XRAY
Q4 25
$994.8M
$961.0M
Q3 25
$1.1B
$904.0M
Q2 25
$1.4B
$936.0M
Q1 25
$1.3B
$879.0M
Q4 24
$1.4B
$905.0M
Q3 24
$1.5B
$951.0M
Q2 24
$1.4B
$984.0M
Q1 24
$1.2B
$953.0M
Net Profit
GEF
GEF
XRAY
XRAY
Q4 25
$174.6M
$-146.0M
Q3 25
$64.0M
$-427.0M
Q2 25
$47.3M
$-45.0M
Q1 25
$8.6M
$20.0M
Q4 24
$70.1M
$-430.0M
Q3 24
$87.1M
$-494.0M
Q2 24
$44.4M
$-4.0M
Q1 24
$67.2M
$18.0M
Gross Margin
GEF
GEF
XRAY
XRAY
Q4 25
20.4%
46.1%
Q3 25
22.7%
48.8%
Q2 25
23.1%
52.4%
Q1 25
19.4%
53.0%
Q4 24
20.4%
49.3%
Q3 24
20.0%
52.1%
Q2 24
19.7%
51.9%
Q1 24
18.4%
53.1%
Operating Margin
GEF
GEF
XRAY
XRAY
Q4 25
25.8%
-14.5%
Q3 25
6.4%
-24.1%
Q2 25
8.6%
-13.7%
Q1 25
4.7%
7.2%
Q4 24
8.9%
-56.2%
Q3 24
11.8%
-48.6%
Q2 24
7.2%
5.1%
Q1 24
5.7%
4.4%
Net Margin
GEF
GEF
XRAY
XRAY
Q4 25
17.6%
-15.2%
Q3 25
5.6%
-47.2%
Q2 25
3.4%
-4.8%
Q1 25
0.7%
2.3%
Q4 24
4.9%
-47.5%
Q3 24
6.0%
-51.9%
Q2 24
3.2%
-0.4%
Q1 24
5.6%
1.9%
EPS (diluted)
GEF
GEF
XRAY
XRAY
Q4 25
$-0.74
Q3 25
$-2.14
Q2 25
$-0.22
Q1 25
$0.10
Q4 24
$-2.09
Q3 24
$-2.46
Q2 24
$-0.02
Q1 24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GEF
GEF
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$243.5M
$326.0M
Total DebtLower is stronger
$655.1M
$2.3B
Stockholders' EquityBook value
$2.9B
$1.3B
Total Assets
$5.5B
$5.4B
Debt / EquityLower = less leverage
0.22×
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GEF
GEF
XRAY
XRAY
Q4 25
$243.5M
$326.0M
Q3 25
$285.2M
$363.0M
Q2 25
$252.7M
$359.0M
Q1 25
$201.1M
$398.0M
Q4 24
$197.7M
$272.0M
Q3 24
$194.2M
$296.0M
Q2 24
$196.0M
$279.0M
Q1 24
$179.3M
$291.0M
Total Debt
GEF
GEF
XRAY
XRAY
Q4 25
$655.1M
$2.3B
Q3 25
$2.3B
Q2 25
$2.4B
Q1 25
$2.5B
Q4 24
$2.7B
$1.7B
Q3 24
$2.9B
Q2 24
$2.9B
Q1 24
$2.3B
Stockholders' Equity
GEF
GEF
XRAY
XRAY
Q4 25
$2.9B
$1.3B
Q3 25
$2.2B
$1.5B
Q2 25
$2.1B
$2.0B
Q1 25
$2.0B
$2.0B
Q4 24
$2.1B
$1.9B
Q3 24
$2.1B
$2.5B
Q2 24
$2.0B
$3.1B
Q1 24
$2.0B
$3.3B
Total Assets
GEF
GEF
XRAY
XRAY
Q4 25
$5.5B
$5.4B
Q3 25
$6.7B
$5.7B
Q2 25
$6.8B
$6.1B
Q1 25
$6.6B
$6.0B
Q4 24
$6.6B
$5.8B
Q3 24
$6.8B
$6.6B
Q2 24
$6.8B
$6.9B
Q1 24
$6.0B
$7.1B
Debt / Equity
GEF
GEF
XRAY
XRAY
Q4 25
0.22×
1.70×
Q3 25
1.06×
Q2 25
1.12×
Q1 25
1.24×
Q4 24
1.31×
0.90×
Q3 24
1.41×
Q2 24
1.44×
Q1 24
1.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GEF
GEF
XRAY
XRAY
Operating Cash FlowLast quarter
$-24.4M
$101.0M
Free Cash FlowOCF − Capex
$60.0M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
4.3%
Cash ConversionOCF / Net Profit
-0.14×
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GEF
GEF
XRAY
XRAY
Q4 25
$-24.4M
$101.0M
Q3 25
$197.7M
$79.0M
Q2 25
$136.4M
$48.0M
Q1 25
$-30.8M
$7.0M
Q4 24
$187.2M
$87.0M
Q3 24
$76.8M
$141.0M
Q2 24
$87.5M
$208.0M
Q1 24
$4.5M
$25.0M
Free Cash Flow
GEF
GEF
XRAY
XRAY
Q4 25
$60.0M
Q3 25
$40.0M
Q2 25
$16.0M
Q1 25
$-12.0M
Q4 24
$36.0M
Q3 24
$98.0M
Q2 24
$156.0M
Q1 24
$-9.0M
FCF Margin
GEF
GEF
XRAY
XRAY
Q4 25
6.2%
Q3 25
4.4%
Q2 25
1.7%
Q1 25
-1.4%
Q4 24
4.0%
Q3 24
10.3%
Q2 24
15.9%
Q1 24
-0.9%
Capex Intensity
GEF
GEF
XRAY
XRAY
Q4 25
4.3%
Q3 25
4.3%
Q2 25
3.4%
Q1 25
2.2%
Q4 24
5.6%
Q3 24
4.5%
Q2 24
5.3%
Q1 24
3.6%
Cash Conversion
GEF
GEF
XRAY
XRAY
Q4 25
-0.14×
Q3 25
3.09×
Q2 25
2.88×
Q1 25
-3.58×
0.35×
Q4 24
2.67×
Q3 24
0.88×
Q2 24
1.97×
Q1 24
0.07×
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GEF
GEF

Other$501.0M50%
Sustainable Fiber Solutions Segment$300.4M30%
Customized Polymer Solutions Segment$124.8M13%
Durable Metal Solutions Segment$62.5M6%
Innovative Closure Solutions Segment$6.1M1%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons